Use of pharmaceutical nanotechnology for the treatment of leishmaniasis.

Rev Soc Bras Med Trop 2019 Apr 11;52:e20180246. Epub 2019 Apr 11.

Programa de Pós-Graduação em Biotecnologia Industrial, Universidade Tiradentes, Aracaju, SE, Brasil.

Introduction: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects.

Methods: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis.

Results: Our findings revealed a stable number of patents and scientific articles published over the past five years.

Conclusions: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.

Download full-text PDF

Source
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S
Publisher Site
http://dx.doi.org/10.1590/0037-8682-0246-2018DOI Listing
April 2019
2 Reads

Publication Analysis

Top Keywords

nanotechnology treatment
12
treatment leishmaniasis
8
patents scientific
8
scientific articles
8
study investigated
4
investigated literature
4
literature including
4
including patents
4
effectsmethods study
4
minimizing side
4
nanotechnology promise
4
promise improving
4
improving efficacy
4
efficacy bioavailability
4
side effectsmethods
4
identify advances
4
articles published
4
number patents
4
published yearsconclusions
4
yearsconclusions intensify
4

References

(Supplied by CrossRef)
The direct costs of treating human visceral leishmaniasis in Brazil
de Assis TSM et al.
Rev Soc Bras Med Trop 2017

Frézard F et al.
2017
An update on pharmacotherapy for leishmaniasis
Sundar S et al.
Expert Opin Pharmacother 2015
Mannose-conjugated curcumin-chitosan nanoparticles: efficacy and toxicity assessments against Leishmania donovani
Chaubey P et al.
Int J Biol Macromol 2018

Similar Publications